Patent ID: 8399681
Filing Date: 2013-03-19
Classification: A61P,C07D

Abstract:
1. A method of treating a subject suffering from or diagnosed with a disease, disorder, or condition mediated by ERR-α activity, comprising administering to the subject a therapeutically effective amount of at least one compound of Formula (I) wherein X is —CH— or N; R R R is a 4 to 9 membered heterocyclyl bonded to the rest of the molecule through a ring nitrogen atom and optionally containing 1-2 heteroatoms in addition to said ring nitrogen atom, wherein the optional 1-2 additional heteroatoms are independently selected from the group consisting of N, O and S; wherein said 4 to 9 membered heterocyclyl may be substituted with C —N(R —N(R wherein said C wherein said heteroaryl may be substituted with C wherein said heterocyclyl may be substituted with C wherein said C wherein R